OSI Systems

FORMER LUCIRA EVP & CQO JOINS IDENTIFYSENSORS AS EVP & CHIEF QUALITY OFFICER

Retrieved on: 
Tuesday, February 21, 2023

CLEVELAND, Feb. 21, 2023 /PRNewswire/ -- IdentifySensors® Biologics, the leading developer of digital diagnostic technologies, has named industry veteran Ghazi Kashmolah executive vice president regulatory affairs and chief quality officer. Kashmolah joins the company from Lucira Health, where he served as chief quality officer and executive vice president regulatory affairs.

Key Points: 
  • CLEVELAND, Feb. 21, 2023 /PRNewswire/ -- IdentifySensors® Biologics, the leading developer of digital diagnostic technologies, has named industry veteran Ghazi Kashmolah executive vice president regulatory affairs and chief quality officer.
  • Kashmolah joins the company from Lucira Health, where he served as chief quality officer and executive vice president regulatory affairs.
  • The company's initial product, Check4®, is a diagnostics platform that digitally detects infections through graphene-based biosensors within five minutes.
  • The technology has been incorporated into a portable Bluetooth device for rapid results of multiple pathogens.

OSI Systems to Present at Cowen’s 44th Aerospace/Defense & Industrials Conference

Retrieved on: 
Tuesday, February 14, 2023

OSI Systems, Inc. (NASDAQ: OSIS) today announced that it will present at the Cowen 44th Annual Aerospace/Defense & Industrials Conference on Wednesday, February 15, 2023, at 1:20 PM ET.

Key Points: 
  • OSI Systems, Inc. (NASDAQ: OSIS) today announced that it will present at the Cowen 44th Annual Aerospace/Defense & Industrials Conference on Wednesday, February 15, 2023, at 1:20 PM ET.
  • To listen to the live web cast of the presentation, please visit the investor relations section of the OSI Systems website and follow the link from the front page.

OSI Systems Receives $3 Million Order for Patient Monitoring Systems

Retrieved on: 
Wednesday, February 1, 2023

OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare®, received an order valued at approximately $3 million to provide patient monitoring solutions and support services to a Canadian based hospital.

Key Points: 
  • OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare®, received an order valued at approximately $3 million to provide patient monitoring solutions and support services to a Canadian based hospital.
  • The Company expects to provide Xhibit® Central Stations, AriaTele® telemetry, Xprezzon®, Qube® and Qube Mini® patient monitors along with its Clinical Access® decision support and interface software.
  • “We are delighted to receive this significant order and to provide this customer with the breadth of our hardware, patient management and connectivity solutions,” commented Deepak Chopra, OSI Systems’ Chairman and CEO.

OSI Systems Reports Fiscal 2023 Second Quarter Financial Results

Retrieved on: 
Thursday, January 26, 2023

OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for the three and six months ended December 31, 2022.

Key Points: 
  • OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced its financial results for the three and six months ended December 31, 2022.
  • Given our significant backlog and pipeline of opportunities, we anticipate strong revenue and adjusted earnings growth for the balance of fiscal 2023.”
    For the second quarter of fiscal 2023, the Company reported revenues of $295.6 million, a 7% increase compared to the $276.7 million reported for the second quarter of fiscal 2022.
  • Net income for the second quarter of fiscal 2023 was $16.4 million, or $0.96 per diluted share, compared to net income of $19.8 million, or $1.09 per diluted share, for the second quarter of fiscal 2022.
  • Non-GAAP net income for the second quarter of fiscal 2023 was $20.4 million, or $1.19 per diluted share, compared to non-GAAP net income for the second quarter of fiscal 2022 of $23.2 million, or $1.28 per diluted share.

OSI Systems Announces Second Quarter Conference Call

Retrieved on: 
Wednesday, January 18, 2023

OSI Systems, Inc. (Nasdaq: OSIS) today announced that it will hold its quarterly conference call on Thursday, January 26, 2023 at 9:00am PT to discuss its results for the quarter ended December 31, 2022.

Key Points: 
  • OSI Systems, Inc. (Nasdaq: OSIS) today announced that it will hold its quarterly conference call on Thursday, January 26, 2023 at 9:00am PT to discuss its results for the quarter ended December 31, 2022.
  • A replay of the conference call will be available from 12:00pm PT on January 26, 2023 until February 9, 2023.
  • The replay may be accessed by visiting the investor relations section at www.osi-systems.com .

OSI Systems Receives $200 Million+ International Order for Cargo and Vehicle Inspection Systems

Retrieved on: 
Tuesday, January 17, 2023

(the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Security division has received an award with a value exceeding $200 million from an international customer to provide security infrastructure utilizing the Company’s broad portfolio of cargo and vehicle inspection systems, which include mobile and fixed platforms.

Key Points: 
  • (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Security division has received an award with a value exceeding $200 million from an international customer to provide security infrastructure utilizing the Company’s broad portfolio of cargo and vehicle inspection systems, which include mobile and fixed platforms.
  • In addition to providing these systems, the Company expects to manage the civil works to support the deployments, and provide operator training and follow-on maintenance.
  • OSI Systems’ Chairman and CEO, Deepak Chopra, stated, “We are delighted to utilize our proven solutions for this major security initiative, which further expands our presence in a key region.
  • We have extensive experience on major security programs worldwide and now look forward to supporting this customer’s efforts to improve security.”

Worldwide Fetal Monitoring Industry to 2029 - by Product, Portability, Method, Application, End-use and Region - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 14, 2022

Rising incidences of cardiopulmonary illness and preterm births coupled with birth complications is a key driver for the growth of the global fetal monitoring market.

Key Points: 
  • Rising incidences of cardiopulmonary illness and preterm births coupled with birth complications is a key driver for the growth of the global fetal monitoring market.
  • This is attributed to rising awareness for fetal care and monitoring, thereby by minimized miscarriages and abnormal neonate birth rate.
  • Based on application, the market is categorized into intrapartum fetal monitoring and antepartum fetal monitoring.
  • The fetal monitoring market report is categorized into the following segments and subsegments:
    View source version on businesswire.com: https://www.businesswire.com/news/home/20221214005538/en/

$375+ Million Bone Densitometer (DEXA, Peripheral) Markets: Increasing Prevalence of Osteoporosis to Drive the Market for Bone Densitometers - Global Forecast to 2027 - ResearchAndMarkets.com

Retrieved on: 
Friday, December 2, 2022

The global bone densitometer market is projected to reach USD 378 million by 2027 from USD 299 million in 2022, at a CAGR of 4.7% during the forecast period.

Key Points: 
  • The global bone densitometer market is projected to reach USD 378 million by 2027 from USD 299 million in 2022, at a CAGR of 4.7% during the forecast period.
  • The axial bone densitometry segment is expected to account for the largest share of the bone densitometer market.
  • The osteoporosis & osteopenia diagnosis segment is expected to account for the largest share of the bone densitometer market.
  • The osteoporosis & osteopenia diagnosis segment accounted for the largest share of the global bone densitometer market in 2021.

OSI Systems Reports Fiscal 2023 First Quarter Financial Results

Retrieved on: 
Thursday, October 27, 2022

OSI Systems, Inc. (the Company or OSI Systems) (NASDAQ: OSIS) today announced its financial results for the quarter ended September 30, 2022.

Key Points: 
  • OSI Systems, Inc. (the Company or OSI Systems) (NASDAQ: OSIS) today announced its financial results for the quarter ended September 30, 2022.
  • For the first quarter of fiscal 2023, the Company reported revenues of $268.1 million, a 4% decrease compared to the $279.3 million reported for the first quarter of fiscal 2022.
  • Mr. Chopra commented, The Security divisions bookings were strong in the first fiscal quarter of fiscal 2023, leading to an increase in the quarter-end backlog.
  • The financial results calculated in accordance with GAAP and reconciliations from those financial results should be carefully evaluated.

OSI Systems Announces First Quarter Conference Call

Retrieved on: 
Thursday, October 20, 2022

OSI Systems, Inc. (Nasdaq: OSIS) today announced that it will hold its quarterly conference call on Thursday, October 27, 2022 at 9:00am PT to discuss its results for the quarter ended September 30, 2022.

Key Points: 
  • OSI Systems, Inc. (Nasdaq: OSIS) today announced that it will hold its quarterly conference call on Thursday, October 27, 2022 at 9:00am PT to discuss its results for the quarter ended September 30, 2022.
  • A replay of the conference call will be available from 12:00pm PT on October 27, 2022 until November 11, 2022.
  • OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries.
  • For more information on OSI Systems and its subsidiary companies, visit www.osi-systems.com .